Award
Delivery Order #SPE2DR26FQW9B
Short-Term Delivery Order for Pharmaceutical Supply to Government Agency
Buyer
Defense Logistics Agency
Award Amount
$278.50
Ceiling
$278.50
Awarded
February 13, 2026
Period of Performance
Feb 13, 2026 – Feb 17, 2026
Identifier
SPE2DR26FQW9B
NAICS
424210
This award represents a delivery order contract issued under an existing indefinite delivery vehicle (IDV) previously awarded to AmerisourceBergen Drug Corporation, a prominent pharmaceutical distribution company. The contract involves the procurement of a specific pharmaceutical product, Labetalol HCL 100 mg/20 ml vials, essential for medical and healthcare needs within the government sector. The significance of this contract lies in its support for the continuous availability of critical medications to public healthcare systems, ensuring timely and reliable drug supply. The work covered by this contract is limited in scope and duration, focusing on the delivery of the specified pharmaceutical product within a short, defined timeframe. This award followed the terms of the current IDV, indicating a non-competitive processes typical of task or delivery orders executed under broader agreements. Key details include the performance location in Conshohocken, Pennsylvania, and the contract period spanning a few days in mid-February 2026. While no subcontractors or additional solicitations are listed, this award complements the agency's overarching pharmaceutical supply efforts governed by the parent contract.
Description
4570854515!LABETALOL HCL 100 MG/20 ML VL 20ML